Last updated: 23 September 2019 at 4:26pm EST

Alfred G Merriweather Net Worth




The estimated Net Worth of Alfred G Merriweather is at least $444 Thousand dollars as of 20 September 2019. Alfred Merriweather owns over 1,584 units of Adamas Pharmaceuticals Inc stock worth over $394,716 and over the last 7 years Alfred sold ADMS stock worth over $49,728.

Alfred Merriweather ADMS stock SEC Form 4 insiders trading

Alfred has made over 3 trades of the Adamas Pharmaceuticals Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently Alfred sold 1,584 units of ADMS stock worth $10,945 on 20 September 2019.

The largest trade Alfred's ever made was selling 1,665 units of Adamas Pharmaceuticals Inc stock on 21 September 2018 worth over $31,935. On average, Alfred trades about 684 units every 61 days since 2017. As of 20 September 2019 Alfred still owns at least 48,019 units of Adamas Pharmaceuticals Inc stock.

You can see the complete history of Alfred Merriweather stock trades at the bottom of the page.



What's Alfred Merriweather's mailing address?

Alfred's mailing address filed with the SEC is C/O ADAMAS PHARMACEUTICALS, INC., 1900 POWELL ST., SUITE 1000, EMERYVILLE, CA, 94608.

Insiders trading at Adamas Pharmaceuticals Inc

Over the last 11 years, insiders at Adamas Pharmaceuticals Inc have traded over $26,222,162 worth of Adamas Pharmaceuticals Inc stock and bought 1,128,061 units worth $17,799,399 . The most active insiders traders include Point Partners Llcjay Jeffr..., David L Mahoney, and William W. Ericson. On average, Adamas Pharmaceuticals Inc executives and independent directors trade stock every 25 days with the average trade being worth of $254,236. The most recent stock trade was executed by Vijay Shreedhar on 21 June 2021, trading 6,200 units of ADMS stock currently worth $31,992.



What does Adamas Pharmaceuticals Inc do?

Adamas Pharmaceuticals Inc. delivers innovative medicines that reduce the burden of neurological diseases on patients, caregivers and society. The company is a fully integrated company focused on growing a portfolio of therapies to address a range of neurological diseases.



What does Adamas Pharmaceuticals Inc's logo look like?

Adamas Pharmaceuticals Inc logo

Complete history of Alfred Merriweather stock trades at Adamas Pharmaceuticals Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
20 Sep 2019 Alfred G Merriweather
Chief Financial Officer
Sale 1,584 $6.91 $10,945
20 Sep 2019
48,019
20 Mar 2019 Alfred G Merriweather
Chief Financial Officer
Sale 857 $7.99 $6,847
20 Mar 2019
24,603
21 Sep 2018 Alfred G Merriweather
Chief Financial Officer
Sale 1,665 $19.18 $31,935
21 Sep 2018
25,460


Adamas Pharmaceuticals Inc executives and stock owners

Adamas Pharmaceuticals Inc executives and other stock owners filed with the SEC include: